245 related articles for article (PubMed ID: 22608892)
1. Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.
Park H; Otani H; Noda T; Sato D; Okazaki T; Ueyama T; Iwasaka J; Yamamoto Y; Iwasaka T
Int J Cardiol; 2013 Aug; 167(4):1547-51. PubMed ID: 22608892
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction.
Kiyokuni M; Konishi M; Sakamaki K; Kawashima C; Narikawa M; Doi H; Iwata K; Tomari S; Nakayama N; Komura N; Mitsuhashi T; Yano H; Sugano T; Ishigami T; Endo T; Ishikawa T; Yamanaka T; Kimura K
Int J Cardiol; 2016 Oct; 221():321-6. PubMed ID: 27404699
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs.
Park H; Otani H; Oishi C; Fujikawa M; Yamashita K; Okazaki T; Sato D; Ueyama T; Iwasaka J; Yamamoto Y; Iwasaka T
Int J Cardiol; 2011 Feb; 146(3):347-53. PubMed ID: 19709770
[TBL] [Abstract][Full Text] [Related]
4. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
Hoshi T; Sato A; Nishina H; Kakefuda Y; Wang Z; Noguchi Y; Aonuma K
J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Early Intravenous Landiolol on Myocardial Salvage in Patients with ST-segment Elevation Myocardial Infarction before Primary Percutaneous Coronary Intervention: A Randomized Study.
Miyamoto M; Osawa K; Miyoshi T; Mori A; Yoshikawa M; Oka T; Ichikawa K; Nakamura K; Ito H
Acta Med Okayama; 2021 Jun; 75(3):289-297. PubMed ID: 34176932
[TBL] [Abstract][Full Text] [Related]
6. Perioperative use of a beta blocker in coronary artery bypass grafting.
Ogawa S; Okawa Y; Goto Y; Aoki M; Baba H
Asian Cardiovasc Thorac Ann; 2013 Jun; 21(3):265-9. PubMed ID: 24570490
[TBL] [Abstract][Full Text] [Related]
7. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker.
Wang FW; Osman A; Otero J; Stouffer GA; Waxman S; Afzal A; Anzuini A; Uretsky BF
Circulation; 2003 Jun; 107(23):2914-9. PubMed ID: 12771007
[TBL] [Abstract][Full Text] [Related]
8. Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Hanada K; Higuma T; Nishizaki F; Sukekawa T; Yokota T; Yamada M; Saito S; Kushibiki M; Oikawa K; Abe N; Tomita H; Osanai T; Okumura K
Circ J; 2012; 76(2):439-45. PubMed ID: 22156314
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.
Kiyokuni M; Konishi M; Saigusa Y; Iwata K; Nakayama N; Komura N; Sugano T; Ishigami T; Ishikawa T; Yamanaka T; Tamura K; Kimura K
Heart Vessels; 2020 Nov; 35(11):1510-1517. PubMed ID: 32533314
[TBL] [Abstract][Full Text] [Related]
10. Effect of landiolol hydrochloride after off-pump coronary artery bypass.
Maisawa K; Yamazaki K; Ishitoya H; Shimamura Y
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):170-5. PubMed ID: 24532615
[TBL] [Abstract][Full Text] [Related]
11. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.
Zhu TQ; Zhang Q; Qiu JP; Jin HG; Lu L; Shen J; Zhao LP; Zhang RY; Hu J; Yang ZK; Shen WF
Int J Cardiol; 2013 May; 165(3):437-43. PubMed ID: 21940058
[TBL] [Abstract][Full Text] [Related]
13. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study.
Mangiacapra F; Peace AJ; Di Serafino L; Pyxaras SA; Bartunek J; Wyffels E; Heyndrickx GR; Wijns W; De Bruyne B; Barbato E
J Am Coll Cardiol; 2013 Feb; 61(6):615-21. PubMed ID: 23290547
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
[TBL] [Abstract][Full Text] [Related]
16. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
18. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case].
Shimomura T; Fujii G; Suzuki S; Miyahara K; Matsuura A; Yoshida K; Kasamatsu M
Kyobu Geka; 2004 Mar; 57(3):229-32. PubMed ID: 15035081
[TBL] [Abstract][Full Text] [Related]
20. [Effect of landiolol and combined use of landiolol and olprinone on hemodynamics in patients undergoing off-pump coronary artery bypass grafting].
Tachikawa M; Shimazaki M; Arai T; Saima S; Adachi E; Okuda Y
Masui; 2012 Jun; 61(6):566-73. PubMed ID: 22746016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
